These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. Ganzel C; Ben-Chetrit E Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844 [No Abstract] [Full Text] [Related]
6. A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination. Ball-Burack MR; Kosowsky JM J Emerg Med; 2022 Aug; 63(2):e62-e65. PubMed ID: 35690533 [TBL] [Abstract][Full Text] [Related]
7. A case of quadrantic capillaropathy. Higgins EM; Cox NH Dermatologica; 1990; 180(2):93-5. PubMed ID: 2311802 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura. Shah H; Kim A; Sukumar S; Mazepa M; Kohli R; Braunstein EM; Brodsky RA; Cataland S; Chaturvedi S Blood; 2022 Apr; 139(16):2570-2573. PubMed ID: 35259252 [No Abstract] [Full Text] [Related]
9. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19. Wollina U Dermatol Ther; 2020 Jul; 33(4):e13766. PubMed ID: 32500580 [No Abstract] [Full Text] [Related]
10. Pigmented purpuric dermatosis associated with primary antiphospholipid syndrome. Yildiz F; Tas DA; Açikalin A; Karakas T; Kalyoncu U; Erken E Intern Med; 2013; 52(11):1255-7. PubMed ID: 23728566 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review. Abdelmaksoud A; Wollina U; Temiz SA; Hasan A Dermatol Ther; 2022 Jun; 35(6):e15458. PubMed ID: 35306713 [TBL] [Abstract][Full Text] [Related]
12. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual. Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890 [No Abstract] [Full Text] [Related]
13. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination. Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382 [No Abstract] [Full Text] [Related]
14. Sarcoidal immune reaction following SARS-CoV-2 vaccination. Abu Rached N; Mansour R; Susok L; Fried S; Abolmaali N; Lee YP; Gambichler T Clin Exp Dermatol; 2022 May; 47(5):970-972. PubMed ID: 34978352 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. Schulze-Koops H; Specker C; Skapenko A RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439 [TBL] [Abstract][Full Text] [Related]